Helminthic Therapy

Faced

with

chronic

diseases

such

as

severe

allergies,

inflammatory

bowel

diseases,

or

certain

autoimmune

disorders,

some

patients

who

have

not

responded

to

conventional

treatments

explore

alternative

paths.

Among

them,

helminthic

self-

therapy

is

gaining

increasing

interest:

it

involves

voluntarily

introducing

intestinal

worms (

called

helminths),

natural

parasites

of

the

human

body,

into

the

organism.

The

goal?

To

reduce

inflammation

and

calm

an

overly

aggressive

immune

system.

This

practice,

still

experimental,

is

developing

outside

traditional

medical

channels,

particularly

through

online

support

groups.

Some

draw

a

parallel

with

phage

therapy (

using

viruses

to

target

bacteria),

which

has

also

been

revived

in

the

face

of

certain

therapeutic

dead

ends.

The

link

between

excessive

hygiene

and

the

rise

of

autoimmune

diseases

has

been

highlighted

by

research

for

several

decades.

In

industrialized

countries,

where

deworming

campaigns

have

nearly

eradicated

these

worms,

there

is

a

significant

increase

in

chronic

inflammatory

diseases.

Studies

have

then

attempted

to

reintroduce

certain

parasites

in

a

controlled

environment,

with

sometimes

very

encouraging

results:

in

the

United

States,

for

example,

a

study

showed

improvement

in

patients

with

Crohn's

disease

after

ingesting

helminth

eggs.

A

scientific

journal,

the

Journal

of

Helminthology

,

affiliated

with

the

University

of

Cambridge,

has

been

compiling

research

on

this

approach

for

over

40

years.

It

reminds

us

that

helminths

have

already

demonstrated

their

potential

in

treating

inflammatory

and

autoimmune

diseases,

as

well

as

disorders

like

depression

and

anxiety.

However,

this

self-

therapy

raises

many

ethical

and

medical

questions.

Practiced

without

professional

supervision,

it

is

not

without

risks.

It

embodies

both

the

boldness

of

patients

seeking

solutions...

and

the

necessity

of

an

open

dialogue

between

therapeutic

innovation

and

safety.